Skip to main content
Gabriel Tinoco Suarez, MD, Oncology, Columbus, OH

Gabriel Ricardo Tinoco Suarez MD FACP

Hematologic Oncology, Sarcoma


Associate Professor of Medicine, Ohio State University.

Join to View Full Profile
  • 460 W 10th AveColumbus, OH 43210

  • Phone+1 614-293-0463

  • Fax+1 614-293-1704

Dr. Tinoco Suarez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Gabriel Tinoco is a distinguished oncologist based in Columbus, OH, specializing in sarcomas. He earned his medical degree from the National University of Colombia in 2005, followed by an internal medicine residency at MedStar Health/Harbor Hospital (2008–2011). He then completed a fellowship in hematology and medical oncology at the University of Miami/Jackson Health System (2013–2016).

    Dr. Tinoco's expertise encompasses sarcomas, personalized medicine, and clinical trials. He has received multiple research grants, authored numerous peer-reviewed publications, and plays a pivotal role in investigator-initiated trials. As a leading expert in clinical trial design and execution, he actively contributes to advancing cancer treatment through innovative research in sarcomas.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016
  • MedStar Health Georgetown University/Harbor Hospital
    MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 2008 - 2011
  • National University of Colombia
    National University of ColombiaClass of 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2011 - 2027
  • OH State Medical License
    OH State Medical License 2016 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondr...  
    Luyuan Li, Ana C Paz, Breelyn A Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C Trent, PloS one, 9/14/2015
  • The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.  
    Tinoco G, Wilky BA, Paz-Mejia A, Rosenberg A, Trent JC, Am Soc Clin Oncol Educ Book., 5/2015

Professional Memberships

Other Languages

  • Spanish, Portuguese

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: